Factors important to salivary immune responses which can effectively modify colonization and/or virulence of pathogenic microbiota include ontogenic development, subclass restriction, route of antigen administration, antigen presentation, and anamnesis. In the infant a still-maturing secretory immune system is confronted with increasingly complex infectious challenges by potentially pathogenic oral flora. Later in life the pathways available for protective secretory immune responses are more varied and include a unique system for expression of secretory immunity in microenvironments throughout the oral cavity, namely, the minor salivary gland network. This proposal will explore, in infants and young children, the development of the secretory immune system through its interaction with indigenous microbiota by: 1) comparison of the development of salivary antibody to oral streptococcal antigens in ELISA-Ab with infection by oral streptococci; 2) measurement of the progressive complexity of salivary antibody responses to epitopes from an infant's own oral flora by Western blotting; 3) identification of the ontogeny measurement of initial salivary antibody response to injection of B.pertussis antigens and anamnestic responses to injected (tetanus toxoid) and orally administered (poliovirus) vaccines, in ELISA-Ab. Also explored will be the potential for mature salivary immune expression in minor (labial) salivary gland saliva (LS) by 5) identifying IgG and IgA concentration by ELISA -Ig in LS from children, adolescents, young and older adults; 6) measuring the distinctiveness of LS IgA and IgG isotypic and subclass antibody, using a) Western blot analysis of LS, parotid and serum antibody to a battery of oral antigens, and b) isoelectric focusing/Western blot analysis of antibody spectrotypes to individual antigens; and 7) exploring the potential for stimulation gLS IgA and IgG antibody and antibody-secreting peripheral blood monocytes by topical or systemic immunization with tetanus toxoid, and 8) the possibility for enhancing LS antibody responses by combining systemic immunization with local application of antigen. These studies should a) provide new basic information about the ontogeny of salivary immunity, b)identify virulence antigens which are immunogenic during the initial colonization period and which thus could be incorporated into a dental caries vaccine, c) help to clarify the role of the minor salivary gland network in oral immunity, and d) identify the potential for specific enhancement of LS immunity by immunization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE006153-07A1
Application #
3219877
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1982-08-01
Project End
1994-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Forsyth Institute
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Smith, Daniel J (2010) Dental caries vaccines: prospects and concerns. Expert Rev Vaccines 9:1-3
Peacock, Zachary S; Cox, Darren; Schmidt, Brian L (2010) Involvement of PTCH1 mutations in the calcifying epithelial odontogenic tumor. Oral Oncol 46:387-92
Klein, Marlise I; Bang, Sungyon; Florio, Flavia M et al. (2006) Genetic diversity of competence gene loci in clinical genotypes of Streptococcus mutans. J Clin Microbiol 44:3015-20
Peacock, Z S; Barnes, L A; King, W F et al. (2005) Influence of microparticle formulation on immunogenicity of SYI, a synthetic peptide derived from Streptococcus mutans GbpB. Oral Microbiol Immunol 20:60-4
Smith, Daniel J; King, William F; Rivero, Joy et al. (2005) Immunological and protective effects of diepitopic subunit dental caries vaccines. Infect Immun 73:2797-804
Russell, Michael W; Childers, Noel K; Michalek, Suzanne M et al. (2004) A Caries Vaccine? The state of the science of immunization against dental caries. Caries Res 38:230-5
Smith, D J; Lam, A; Barnes, L A et al. (2003) Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity. Oral Microbiol Immunol 18:240-8
Smith, Daniel J; King, William F; Barnes, Leigh A et al. (2003) Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B. Infect Immun 71:1179-84
Smith, D J; King, W F; Godiska, R (2001) Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infect Immun 69:3135-42
Smith, D J; King, W F; Barnes, L A et al. (2001) Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines. Infect Immun 69:4767-73

Showing the most recent 10 out of 40 publications